Medical Device; Telecommunications; Health Care; Pharmaceutical; Diagnostic; Manufacturing; Utilities; Computer Hardware; Computer Software; Chemical; Insurance; Biotech; Transportation
Medtronic; Maxcom; Eisai; Fluke; ConvaTec; MAPI; MSD; CraftBilt; Astellas; ABC Laboratories; Xanodyne Pharmaceuticals; National Grid; Merck; Ipca Laboratories; Amdocs; Veeda Clinical Research; GlaxoSmithKline; Intas; Grace; MetLife; Lilly; Baxter International; EMD Serono; Boehringer Ingelheim; AstraZeneca; Abbott; Medrad; Amgen; MDS Pharma Services; Alcon; Sanofi-aventis; Vertex Pharmaceuticals; Emirates Group
Participants in this benchmarking research included 32 Communications executives and managers at 28 leading companies from bio-pharmaceutical, healthcare and other industry segments.
Field interviews and study analysis produced many observations and benchmark findings. Key study insights reflect opportunities across the External Communications Function. In terms of effectiveness, many organizations have turned to providing differentiated services in conjunction with customer and/or issue-oriented specialists to support growth and profitability.